• Developing for clients various matrix diffusion tablet/capsule systems for oral sustained/controlled release (usually patentable)

• Designing and developing for client oral disintegration sustained release tablets (ODT-SR) – usually patentable

• Molecular Caging (MC) processed delivery systems for sustained release formulations. MC technology is applicable to solid, liquid, gel, for oral or parenteral administrations.

• Micro and nano particles/capsules and non-conventional delivery systems – usually patentable

• Other types of delivery system (emulsions, micelles, liposome formulations, etc.)

• Matrix diffusion tablet/capsule systems for oral sustained/controlled release

• Oral disintegration sustained release tablets

• Molecular Caging (MC) processed dosage forms for various sustained release formulations applicable to solid, liquid, gel, and for oral or parenteral administrations. Micro and nano particles/capsules and non-conventional delivery systems.

• Liposome formulations

Vanton Patented Drug Delivery Technologies

• Molecular caging platform ( a know-how process Vanton develops for each client’s specific API and dosage form. It is a highly API depending system, applicable to both oral and parenteral administrations

• Orally disintegrating tablet with sustained release (ODT-SR) capability for improving patient compliance and for special applications

• A know-how process for constructing transdermal and topical formulations that can be controlled to deliver drugs for (1) topical, (2) epi-dermis, (3), dermis, and/or systemic c applications

Emulsions

• Semi-solid and liquid emulsion delivery systems for parenteral sustained release dosage forms

• Liquid or solid powder formulations for re-constitution (injection or infusion)

Micro and Nano Particle/Capsules

• Micro and nano delivery systems for oral and parenteral sustained release dosage forms